Circulating tumor cells and early relapse in node-positive melanoma.

CONCLUSION: ≥1 CTC was independently associated with melanoma relapse, suggesting that CTC assessment may be useful to identify patients at risk for relapse who could derive benefit from adjuvant therapy.
PMID: 32015020 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - February 2, 2020 Category: Cancer & Oncology Authors: Lucci A, Hall C, Patel SP, Narendran B, Bauldry JB, Royal R, Karhade M, Upshaw JR, Wargo JA, Glitza IC, Wong MKK, Amaria RN, Tawbi HA, Diab A, Davies MA, Gershenwald JE, Lee JE, Hwu P, Ross MI Tags: Clin Cancer Res Source Type: research